SOST and prostate cancer: Concerning osteocyte involvement into prostate cancer progression in bone, we found that the expression of SOST, an inhibitor of Wnt signaling, was induced by PC3 cells conditioned medium, suggesting a direct effect of osteocytes on OB differentiation during tumor bone progression.